NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
12.26
+0.41 (3.42%)
Mar 31, 2025, 2:33 PM EDT - Market open
NeuroPace Employees
NeuroPace had 184 employees as of December 31, 2024. The number of employees increased by 13 or 7.60% compared to the previous year.
Employees
184
Change (1Y)
13
Growth (1Y)
7.60%
Revenue / Employee
$434,272
Profits / Employee
-$147,505
Market Cap
399.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NPCE News
- 5 days ago - NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 26 days ago - NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 27 days ago - UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 27 days ago - NeuroPace to Present at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd. - GlobeNewsWire
- 5 weeks ago - NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - GlobeNewsWire
- 5 weeks ago - NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire